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Spermadhesin AWN-1 (14 kDa) belongs to a recently described family of boar sperm surface-associated proteins. AWN-1 is a multifunctional 
protein which possesses heparin-, serine proteinase inhibitor-, and zona pellucida glycoprotein-binding capability. Therefore it has been implicated 
in sperm capacitation and sperm-oocyte attachment. Here, we report he characterization f 22-25 kDa isoforms of AWN-1 isolated by heparin- 
affinity chromatography, which fail to bind to zona pellucida glycoproteins or serine proteinase inhibitors. Our results how that the structure of 
the high and low molecular mass AWN-1 forms differ in that the former is N-glycosylated atAsp 5° and truncated at the C-terminus. The inability 
of the glycosylated AWN-1 molecules to bind ligands is due solely to the presence of the oligosaccharide moieties, however. This indicates that 
glycosylation of AWN-1 may modulate its ligand-binding capabilities. On the other hand, the effect of glycosylation on ligand-binding suggests 
that both the zona pellucida- and the serine proteinase inhibitor binding domain(s) may be located around the glycosylation point. 
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1. INTRODUCTION 
Species-specific sperm-egg recognition and binding is 
mediated by a series of interactions between comple- 
mentary molecules located at the surface of homolo- 
gous gametes [1]. In mammals, this biological activity 
involves a carbohydrate-recognition mechanism be- 
tween proteins located on the sperm's acrosomal cap 
and saccharide chains of the oocyte's extracellular ma- 
trix called zona pellucida [2]. A wide variety of mam- 
malian sperm antigens involved in binding to the zona 
pellucida have been described in a number of species 
[2,3]. However, neither are the structural data available 
to compare apparently similar molecules from different 
species, nor has the relative contribution of different 
zona pellucida-binding molecules to the process of 
sperm-egg interaction been evaluated. 
AWN-1 (14 kDa) belongs to a boar sperm-associated 
zona pellucida-binding protein family termed 'spermad- 
hesin' [2,4-6]. It is a multi-functional protein which 
combines within the same molecule zona pellucida 
glycoprotein- [7], heparin- [8], and serine proteinase in- 
hibitor-binding [9] capabilities. This indicates that sper- 
madhesin AWN may play a role in at least two impor- 
tant aspects of pig fertilization, i.e. sperm capacitation 
by heparin-like glycosaminoglycans present in the fe- 
male sexual tract, and primary receptor for oligosac- 
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charide moieties attached to oocyte zona pellucida 
glycoproteins. The molecular features of the AWN-1 
structure responsible for its diverse ligand-recognition 
abilities remain unknown, however. 
In a previous paper [8], we identified a heparin-bind- 
ing protein the N-terminal sequence of which is identical 
to that of AWN-1 but which possesses a higher molecu- 
lar mass (22-25 kDa) and which fails to bind zona 
pellucida glycoproteins and soybean trypsin inhibitor. 
Here, we show that this AWN-like molecule is actually 
a mixture of single-point glycosylated isoforms of 
AWN-1 (G-AWN-1) at Asp s°. Moreover, glycosylation 
appears to be the sole cause of the inability of G-AWN 
to bind both zona pellucida glycoproteins and soybean 
trypsin inhibitor. These data indicate that glycosylation 
may modulate the ligand-binding activity of spermad- 
hesin isoforms. In addition, our results suggest that the 
ligand-binding pocket for zona pellucida oligosac- 
charide(s) and serine proteinase inhibitors may (par- 
tially) overlap within the region where the glycosylation 
site is located. 
2. MATERIALS AND METHODS 
Isolation of boar seminal plasma heparin-binding proteins was done 
by affinity chromatography followed by reverse-phase HPLC as de- 
scribed [8]. 
SDS-polyacrylamide g l electrophoresis was performed according 
to [10]. 
Polyelonal monospecific anti-AWN-1 antibodies were raised in 
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chicken and the IgG fraction was purified from the egg's yolk as 
described [11]. 
For peptide mapping, the isolated proteins (2 mg/ml in 100 mM 
Tris-HCl, 0.5 M guanidine hydrochloride, pH 8.0) were incubated at 
37°C overnight with tosylphenylalanine chlormethane-treated trypsin 
(sequencing rade; Boehringer-Mannheim) at an enzyme/substrate 
ratio of 1:100 (w/w). Enzymatic digestion mixtures were lyophilized 
and the tryptic peptides isolated by reverse-phase HPLC on a Lichro- 
spher RP-100 (Merck) Cl8 column (25 x 0.4 cm, 5/.tm particle size) 
eluting at 1 ml/min with a gradient of 0.1% trifluoroacetic a id in (A) 
water and (B) acetonitrile, first isocratically (5% B) for 5 min followed 
by 5 50% B for 90 min, and 50-70% for 20 min. Peptides were detected 
at 220 nm and manually collected for further analysis. 
Amino acid and amino sugar analyses were done with a Pharmacia- 
LKB Alpha Plus analyzer after hydrolysis at 110°C in 6 M HC1 for 
24 h and 4 M HC1 for 4 h, respectively. N-Terminal sequence analyses 
were performed using an Applied Biosystems 473A sequencer. 
For enzymatic deglycosylation, 0.5 mg of isolated protein (2 mg/ml 
in 50 mM phosphate, pH 7.0) was incubated overnight at 37°C with 
10 U of N-glycosidase F (PNGase F) from Flavobacterium men&go- 
septicum (Boehringer-Mannheim). 
Electroblotting onto nitrocellulose sheets was done following [12]. 
To test the ligand-binding activities of electroblotted proteins (intact 
or deglycosylated), the blots were blocked with 20 mM Tris-HCl, pH 
7.4, 150 mM NaC1, 5% (w/v) BSA, and incubated for 1 h at 37°C with 
either (A) anti-AWN-1 antibody (1:1,000 dilution), washed and incu- 
bated for 1 h at 37°C with a 1:300 (v/v) dilution ofbiotinylated rabbit 
anti-chicken IgG antibody [4], (B) 2.5 ,ug/ml biotinylated pig zona 
pellucida [13], or (C) 15 ,ug/ml biotinylated soybean trypsin inhibitor 
(Sigma) [9]. After extensive washing, the blots were incubated for 1 h 
at 37°C with streptavidin peroxidase (1:1,000), washed with 20 mM 
Tris-HC1, 500 mM NaCI, pH 7.4, and finally developed with this 
buffer containing 20% methanol, 1 mg/ml 4-chloro-l-naphtol (Bio- 
Rad), and 15 pl H202. 
3. RESULTS AND DISCUSSION 
3.1. Biochemical characterization of the A WN-related 
22-25 kDa protein 
To ascertain the degree of structural relationship be- 
tween the boar seminal plasma 22-25 kDa heparin- 
binding protein and AWN-1, we investigated their 
chemical composition, immunological reactivity to- 
wards monospecific polyclonal chicken anti-AWN-1 
antibodies, and peptide maps. 
The amino acid composition of both proteins was 
almost identical, and amino sugar analysis revealed that 
only the 22-25 kDa protein contained glucosamine 
(3.25 mol/100 mol amino acids) (data not shown). To 
investigate whether N-glycosylation was the sole differ- 
ence between the two proteins, the 22-25 kDa protein 
was enzymatically deglycosylated with PNGase F. 
Strikingly, the apparent molecular mass of the deglyco- 
sylated protein was around 2 kDa lower then that of 
native AWN-1 (Fig. 1, lane e). This was not due to a 
protease activity in the PNGaseF preparation since in 
a parallel experiment, the endoglycosidase did not 
cleave isolated AWN-1 (Fig. 1, lane c). On the other 
hand, the three proteins were identified with anti-AWN- 
1 antibodies, indicating that they are closely immunol- 
ogical related (Fig. 2). 
To further characterize the structural differences be- 
tween AWN-1 and the deglycosylated AWN-related 
96 
67 
43 
30 
21 
14 
a b cde  
Fig. 1. Non-reduced SDS-polyacrylamide (10-25%) gel electrophore- 
sis of boar spermadhesin AWN (lane c) and the 22-25 kDa heparin- 
binding AWN-related protein (lane d). Lanes b and e, the same sam- 
ples as in lanes c and d, respectively, after treatment with PNGaseF. 
Lane a, molecular mass standards: from top to bottom, phosphorylase 
b, bovine serum albumin, ovalbumin, carbonic anhydrase, soybean 
trypsin inhibitor, and lysozyme. The numbers at the left indicate mo- 
lecular masses in kDa. 
protein, both were cleaved with trypsin and their tryptic 
peptide maps analyzed by reverse-phase HPLC (Fig. 3). 
The only difference found was the presence of an extra 
peak (labeled 3 in Fig. 3A) in the AWN-1 digest. Amino 
acid analysis of this fragment showed that its composi- 
tion was (in mol/peptide): 2 Thr, 2 Glu/Gln, 1 Ala, 2 Ile, 
and 1 Lys. This clearly indicated that peptide 3 corre- 
sponded to the C-terminal AWN polypeptide stretch 
123-130 [4]. On the other hand, the amino acid compo- 
sition of the common peaks failed to show any differ- 
ences between corresponding pairs. Therefore, we con- 
clude that the 22-25 kDa protein contains a mixture of 
N-glycosylated isoforms of AWN 1-122. 
To localize the glycosylated residue(s), the 22-25 kDa 
was cleaved with trypsin and its tryptic peptide map 
(Fig. 3B) compared with that of AWN-1 (Fig. 3A). 
Amino acid analysis of peak 8 (marked with an asterisk 
in Fig. 3B) showed that it contained the disulphide- 
bonded peptides, 36-55 and 73-82, and amino sugar 
determination revealed the presence of glucosamine 
(not shown). The primary structure of this fragment 
includes the motif 5°Asn-Leu-Ser52 [4], a consensus e- 
quence for N-glycosylation. This is the only NXS/T 
sequence found in AWN-1 [4] and, thus, our results 
strongly suggest that the observed electrophoretic heter- 
ogeneity of the 22 25 kDa isoform of AWN may be due 
to different glycosylation patterns on a single site. 
3.2. The structural basis of the inability of glycosylated 
A WN to bind ligands 
To establish whether the failure of the glycosylated 
AWN-1 isoforms to bind zona pellucida glycoproteins 
38 
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Fig. 2. Detection by immunoblotting analysis of anti-AWN binding 
activity. Lane a, the 22 25 kDa heparin-binding protein; lane b, boar 
spermadhesin AWN; lane c, the 22 25 kDa protein after PNGaseF 
treatment. 
and serine proteinase inhibitor was due to the C-termi- 
nal truncation or to the presence of an oligosaccharide 
chain, we analyzed the ligand-binding capabilities of 
native and PNGaseF-treated 22-25 kDa proteins using 
Western blot. It was found that the deglycosylated low 
molecular mass isoform of AWN-1 was able to bind 
both biotinylated zona pellucida glycoproteins (Fig. 
4A) and biotinylated soybean trypsin inhibitor (Fig. 
4B). These results indicate that glycosylation may regu- 
late the ligand-binding abilities of AWN-I ,  and that the 
C-terminal tail of AWN-1 (residues 123-133) may not 
be necessary for ligand binding. 
It is worth noting that boar spermadhesin AWN-2, 
which is identical to AWN-1 except hat it contains an 
acetylated N-terminus [7], also has 22-25 kDa Asn 5°- 
glycosylated isoforms which show the same ligand- 
binding spectrum as G-AWN-1 (unpublished observa- 
tions). Spermadhesins AWN-1 and AWN-2 have been 
implicated in two important events of sperm function, 
i.e. in sperm capacitation (as a positive extrinsic factor 
by its heparin- and serine proteinase inhibitor-binding 
activities) [8,9] and in sperm-egg binding (as a primary 
counter-receptor for zona pellucida) [4,7]. Hence, the 
suggested hypothesis that glycosylation/deglycosylation 
could represent a mechanism for switching the receptor 
functions of the AWN isoforms deserves further investi- 
gation. 
Finally, the different effect of glycosylation on the 
ligand-binding capabilities of the 22-25 kDa AWN (1 
or 2) isoforms indicates that the protein domain in- 
volved in heparin binding is different from the zona 
pellucida- and serine proteinase inhibitor-binding 
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Fig. 3. Comparison of the reverse-phase HPLC tryptic peptide maps 
of AWN (A), native glycosylated 22-25 kDa protein (B), and the 
22-25 kDa protein after enzymatic deglycosylation with PNGaseF 
(c). 
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Fig. 4. Analysis of the ability of electrotransferred 22-25 kDa protein 
(lane a), AWN (lane b) and PNGaseF-treated 22 25 kDa protein (lane 
c) to bind (A) biotinylated zona pellucida glycoproteins and (B) biot- 
inylated soybean trypsin inhibitor. 
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utors to the ligand-binding pocket surface. Interest- 
ingly, AWN possesses the heparin-binding consensus 
sequence, 3NRRSRS8 (labeled 'Hep'  in Fig. 5), which in 
the AWN molecular model is located at the opposite 
face of  that containing the zona pellucida/inhibitor 
binding sites. This would be in accordance with the fact 
that heparin binding to AWN (isoforms 1 or 2) is not 
affected by glycosylation. Whether this AWN region 
actually contains the heparin binding site needs, how- 
ever, further investigation. 
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Fig. 5. Molecular model of spermadhesin AWN showing its two di- 
sulphide bridges and the position of the glycosylation site (shadowed 
surface), and the putative heparin-binding region (filled polypeptide 
stretch labeled 'Hep'). N, N-terminus; C, C-terminus. 
site(s). On the other hand, the ligand-binding pocket for 
zona pellucida and soybean trypsin inhibitor may, at 
least partially, overlap within an AWN region sur- 
rounding the glycosylation site. This latter conclusion 
agrees with the current hypothesis that the main func- 
tion of  sperm-bound seminal plasma serine proteinase- 
like inhibitors may be the stabilization, or protection, 
of  sperm membrane sites with specificity for oocyte rec- 
ognition, and that release of  the bound inhibitor during 
sperm residence in the uterine tract allows sperm to bind 
to the oocyte's zona pellucida [14,15]. 
Based on a pattern-search approach, Bork and Beck- 
mann [16] have predicted that AWN (and the other boar 
spermadhesins [2]) may belong to the CUB-domain su- 
perfamily of  proteins, the topology of  which may resem- 
ble that of  an immunoglobulin-l ike antiparallel f barrel 
domain. Based on this information, and taking the co- 
ordinates of  the recently solved X-ray structure of  the 
third immunoglobulin-l ike domain of  rat CD4 [17], a 
schematic model for a spermadhesin molecule is de- 
picted in Fig. 5. Should this model turn out to be right, 
then our present data indicate that the binding sites for 
zona pellucida oligosaccharide and soybean trypsin in- 
hibitor may reside within the loop formed between 
Cys 3° and Cys 53, being fl-strands 3 5, the main contrib- 
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